Perda de visão como forma de apresentação de recidiva de carcinoma da mama

Authors

  • Ana E. Sousa Serviço de Oftalmologia, Hospital Universitário de Santa Maria
  • Margarida Lucas Serviço de Oftalmologia, Hospital Universitário de Santa Maria
  • M. João Nunes da Silva Serviço de Oftalmologia, Hospital Universitário de Santa Maria
  • C. Marques Neves Serviço de Oftalmologia, Hospital Universitário de Santa Maria
  • M. Monteiro Grillo Serviço de Oftalmologia, Hospital Universitário de Santa Maria
  • E. Bruno da Costa Serviço de Medicina 2, Hospital Universitário de Santa Maria
  • Rui M. M. Victorino Serviço de Medicina 2, Hospital Universitário de Santa Maria

Keywords:

Breast Cancer, Choroidal Metásta­ses, Tamoxifen, Retinal Detatchment, Loss of Vi­sion

Abstract

We presenta case of a patient in whom thefirst manifestation of breast carcinoma recurrence ten years after the initial diagnosis was a loss of vision as a result of a choroidal metástase. A clear therapeutic response to tamoxifen was seen.

Choroidal metástases are rare in clinicai onco­ logical practice and are considered exceptional as aform of presentation of a recurrence of bre­ast carcinoma. Radiotherapy is the usual palia­tive therapy. This unusual response to tamoxi­fen is emphasized in view of the absence of simi­ lar reports in the literature.

Downloads

Download data is not yet available.

References

- Mewis L, Young S E. Breast carcinoma metastatic to choroid. Analysis of 67 patients. Ophtalmology 1982; 89: 147-151

- Freedman M L, Folk J C. Metastatic tumors to the eye and orbit. Patient survival and clinical characteristics. Arch-Ophtalmo­logy 1987; 105(9): 1215-1219

- Rose M A, Feldman E L. Specific sites of metastatic diseases and emergencies: Choroidal metástases from breast Cancer. ln: Har­ris JR, Hellman S., Henderson IC, Kinne DW (eds). Breast Di­seases. Philadelphia. JB Lippincott 1987; 497-505

- Koda M, Hori T, Maeda N, Kato S, Murawaki Y, Horie Y et al. Lectin-reactive patterns of markedly elevated serum alpha­ fetoprotein in patients with chronic active hepatitis. Am. J. Gastroenterology 1991; 86: 861-865

- Hibbard A D, Harwood L J, Wells J E. Long term prognosis of women with breast cancer in New Zeland. Study of survival to 30 years. Brit. Med.J. 1983; 286: 1777-1779

- Rugist L E, Wallgrew A. Long-term survival of 458 young breast cancer patients. Cancer, 1981; 55: 658-665

- Henderson I C, Harris J R, Kinne D W, Hellman S. Cancer of the breast. ln: DeVita V T, Hellman S, Rosenberg S A, ed. Cancer: principles and practice of oncology. Philadelphia. B. Lippin­cott 1989; 1197-1258

- FDA. Adverse Reactions reports 1987-1990

- Ching C K, Smith P G, Long R G. Tamoxifen associated hepatoce­llular damage and agranulocytosis. Lancet 1992; 339: 940.

- Stricker B H Ch, Biour M and Wilson J H P. Sex hormone anta­gonists and miscellaneous agents. ln Stricker B.H.CH. Ed. Drug induced hepatic injury. Amsterdam. Elsevier 1992; 475-478

Additional Files

Published

1994-03-31

How to Cite

1.
Sousa AE, Lucas M, Nunes da Silva MJ, Marques Neves C, Monteiro Grillo M, Bruno da Costa E, M. M. Victorino R. Perda de visão como forma de apresentação de recidiva de carcinoma da mama. RPMI [Internet]. 1994 Mar. 31 [cited 2024 Dec. 18];1(1):25-8. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/2431

Issue

Section

Case Reports

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)